Volume 62 • 2001 • Supplement 22

Publisher’s Podcast: An Audio Summary of This Issue

Listen to an audio summary of this issue

Subscribe to the Podcast

Introduction: The Role of Enteric-Coated Fluoxetine Once-Weekly in Achieving Optimal Outcomes in the Long-Term Treatment of Depression [Free]

J Clin Psychiatry 2001;62(suppl 22):3-4

The Burden of Recurrent Depression: Causes, Consequences, and Future Prospects

J Clin Psychiatry 2001;62(suppl 22):5-9

Treatment Recommendations Versus Treatment Realities: Recognizing the Rift and Understanding the Consequences

J Clin Psychiatry 2001;62(suppl 22):10-15

Factors Affecting Return of Symptoms 1 Year After Treatment in a 62-Week Controlled Study of Fluoxetine in Major Depression

J Clin Psychiatry 2001;62(suppl 22):16-23

Fluoxetine: A Suitable Long-Term Treatment.

J Clin Psychiatry 2001;62(suppl 22):24-29

Compliance With Antidepressants in a Primary Care Setting, 1: Beyond Lack of Efficacy and Adverse Events.

J Clin Psychiatry 2001;62(suppl 22):30-33

Compliance With Antidepressants in a Primary Care Setting, 2: The Influence of Gender and Type of Impairment

J Clin Psychiatry 2001;62(suppl 22):34-37

Exploring Treatment Alternatives: Weekly Dosing of Fluoxetine for the Continuation Phase of Major Depressive Disorder

J Clin Psychiatry 2001;62(suppl 22):38-42

Patient Compliance With Enteric-Coated Weekly Fluoxetine During Continuation Treatment of Major Depressive Disorder

J Clin Psychiatry 2001;62(suppl 22):43-47

Efficacy and Safety of Weekly Treatment With Enteric-Coated Fluoxetine in Patients With Major Depressive Disorder

J Clin Psychiatry 2001;62(suppl 22):48-52

Patient Perspectives on Once-Weekly Fluoxetine.

J Clin Psychiatry 2001;62(suppl 22):53-57